In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies.
Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors.
Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.
Table of Contents
|2 Lessons Learned from Other Allocation Efforts||59-88|
|3 A Framework for Equitable Allocation of COVID-19 Vaccine||89-144|
|4 Applying the Framework for Equitable Allocation of COVID-19 Vaccine in Various Scenarios||145-156|
|5 Administering and Implementing an Effective and Equitable National COVID-19 Vaccination Program||157-174|
|6 Risk Communication and Community Engagement||175-186|
|7 Achieving Acceptance of COVID-19 Vaccine||187-202|
|8 Ensuring Equity in COVID-19 Vaccine Allocation Globally||203-216|
|Appendix A: Study Methods||217-236|
|Appendix B: Committee and Staff Biosketches||237-252|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Framework for Equitable Allocation of COVID-19 Vaccine...